Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 145,321 | 95,595 | 62,406 | 54,439 | 47,712 |
| Marketable Securities | 76,249 | 105,021 | 128,605 | 145,070 | 154,899 |
| Receivables | 22,489 | 22,098 | 23,258 | 16,841 | 18,266 |
| Inventories | 2,449 | 2,310 | 1,740 | 1,367 | 1,108 |
| TOTAL | $251,302 | $229,968 | $223,007 | $225,115 | $226,337 |
| Non-Current Assets | |||||
| PPE Net | 641 | 430 | 489 | 488 | 599 |
| Investments And Advances | 38,609 | 36,145 | 47,879 | 30,865 | 15,089 |
| Intangibles | 10,490 | 10,806 | 11,122 | 11,438 | 11,754 |
| Other Non-Current Assets | 1,670 | 1,230 | 2,234 | 2,210 | 2,498 |
| TOTAL | $51,410 | $48,611 | $61,724 | $45,001 | $29,940 |
| Total Assets | $302,712 | $278,579 | $284,731 | $270,116 | $256,277 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,962 | 11,688 | 11,598 | 11,072 | 15,842 |
| Other current liabilities | 13,200 | 14,580 | 13,550 | 14,599 | 12,465 |
| TOTAL | $48,632 | $47,028 | $39,277 | $26,112 | $28,832 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 61,928 | 61,310 | 60,692 |
| Other Non-Current Liabilities | 36,428 | 25,747 | 28,869 | 49,529 | 49,523 |
| TOTAL | $36,428 | $25,747 | $90,797 | $110,839 | $110,215 |
| Total Liabilities | $85,060 | $72,775 | $130,074 | $136,951 | $139,047 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,384 | 59,115 | 58,712 | 56,298 | 56,135 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -375,418 | -384,170 | -422,060 | -434,225 | -433,681 |
| Other shareholders' equity | -2,200 | -1,780 | -747 | -2,399 | -2,411 |
| TOTAL | $217,652 | $205,804 | $154,657 | $133,165 | $117,230 |
| Total Liabilities And Equity | $302,712 | $278,579 | $284,731 | $270,116 | $256,277 |